Skip to main content
. 2013 Sep;36(5):476–482. doi: 10.1179/2045772312Y.0000000061

Figure 1.

Figure 1

Plasma IGF-1 concentration across bi-weekly treatment observations. Time point data are reported as group mean (±SD). The mean change in plasma IGF-1 concentration from baseline to week 2 (*P < 0.05), weeks 8 to 10 (*P < 0.05), and weeks 8 to 16 (*P < 0.05) was significant.